Hepatotoxicity associated with antifungal therapy after bone marrow transplantation

scientific article published on 24 June 2005

Hepatotoxicity associated with antifungal therapy after bone marrow transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/431595
P698PubMed publication ID16007525
P5875ResearchGate publication ID7736074

P2093author name stringJohn R Wingard
Helen Leather
P433issue3
P407language of work or nameEnglishQ1860
P921main subjecthepatotoxicityQ1349821
P304page(s)308-310
P577publication date2005-06-24
P1433published inClinical Infectious DiseasesQ5133764
P1476titleHepatotoxicity associated with antifungal therapy after bone marrow transplantation
P478volume41

Reverse relations

cites work (P2860)
Q48202890Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations
Q51092138CYP3A4 Induction by Rifampin: An Alternative Pathway for Vitamin D Inactivation in Patients With CYP24A1 Mutations.
Q34980027Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
Q33876645Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection.
Q34394547The possible efficacy of artichoke in fluconazole related hepatotoxicity.
Q33409652Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B.